Cargando…
Paradoxes of senolytics
Autor principal: | Blagosklonny, Mikhail V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6326665/ https://www.ncbi.nlm.nih.gov/pubmed/30594910 http://dx.doi.org/10.18632/aging.101750 |
Ejemplares similares
-
Anti-aging: senolytics or gerostatics (unconventional view)
por: Blagosklonny, Mikhail V.
Publicado: (2021) -
First evidence that senolytics are effective at decreasing senescent cells in humans
por: Ellison-Hughes, Georgina M.
Publicado: (2020) -
Rapamycin for the aging skin
por: Blagosklonny, Mikhail V.
Publicado: (2019) -
As predicted by hyperfunction theory, rapamycin treatment during development extends lifespan
por: Blagosklonny, Mikhail V.
Publicado: (2022) -
As expected, based on rapamycin-like p53-mediated gerosuppression, mTOR inhibition acts as a checkpoint in p53-mediated tumor suppression
por: Blagosklonny, Mikhail V.
Publicado: (2022)